glp-1 drugs medicare to cover weight loss for $50/month Medicare will negotiate Novo's GLP-1

Published by Cambridge University Press on behalf of the European Psychiatric Association Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of medications that mimic the action of the natural hormone GLP-1, which plays a crucial role in regulating glucose metabolism and various other physiological processes [Reference Drucker1, Reference Trujillo, Nuffer and Smith2]

The cost is also much less expensive than the injectable, potentially making the therapy accessible to more people who would not qualify for insurance to cover it

So here you can see sort of a timeline of weight loss drugs

Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist December 18, 2024 6:45 am EST RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist

Also, this structure optimizes the clinical effects of dulaglutide by protecting it from DPP-4-mediated degradation91)